Abstract
Cancer is a severe disease that causes a significant number of deaths worldwide every year. Treatments have been available, such as cisplatin, to help combat this disease. However, recent studies have shown that the enzyme system glutathione/glutathione S-transferases (GSH/GST) can cause resistance of tumor cells to this type of cancer treatment. Fortunately, there are alternatives, such as using palladium complexes such as [PdCl(C2,N-dmba)(tu)], which have demonstrated effectiveness against cancer cells. However, even these metallopharmaceuticals can be inhibited by GSH/GST system, which can modify the chemical structure of the complex and prevent it from working as an anticancer agent. That’s why it’s crucial to study the reaction between the complex [PdCl(C2 ,N-dmba)(tu)] and L-cysteine using techniques such as NMR, mass spectroscopy, UV-Vis spectroscopy, and stopped-flow. The study of this type of reaction will help researchers understand how these organometallics work in biological systems and how we can improve them to treat cancer more effectively.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
